Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.
about
Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function.Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction.Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery.Study of the possible medical and medication explanatory factors of angiographic outcomes in patients with acute ST elevation myocardial infarction undergoing primary percutaneous intervention.In-hospital daily insulin dose predicts long-term adverse outcome in patients with diabetes with ST-elevation myocardial infarction treated with successful primary percutaneous angioplastyEffect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS)Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxideGlucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary interventionMajor impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 studyReduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.Hyperglycemia in the hospital setting: the case for improved control among non-diabetics.Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome.Prevalence of undiagnosed type 2 diabetes in patients admitted with acute coronary syndrome: the utility of easily reproducible screening methods.The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes.Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction.Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucoseAssociation of Gestational Diabetes Mellitus With Left Ventricular Structure and Function: The CARDIA StudyMMP-9 signaling in the left ventricle following myocardial infarction.Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction.Clinic Predictive Factors for Insufficient Myocardial Reperfusion in ST-Segment Elevation Myocardial Infarction Patients Treated with Selective Aspiration Thrombectomy during Primary Percutaneous Coronary Intervention.The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary interventionAn overview of glycemic control in the coronary care unit with recommendations for clinical management.High incidence of abnormal glucose metabolism in acute coronary syndrome patients at a moderate altitude: A sub-Himalayan study.Predicting the no-reflow phenomenon following successful percutaneous coronary intervention.Prevention and treatment of no-reflow.New strategies for the management of no-reflow after primary percutaneous coronary intervention.Impact of diabetes on postinfarction heart failure and left ventricular remodeling.Predictors of delayed and no-reflow as recognized with Thrombolysis in Myocardial Infarction [TIMI] flow grade following Primary Percutaneous Coronary Angioplasty.Acute hyperglycemia and spontaneous reperfusion in acute myocardial infarction.Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification.A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting.Hyperglycemia in patients referred for cardiac catheterization is associated with preexisting diabetes rather than a stress-related phenomenon: a prospective cross-sectional study.Admission hyperglycemia is associated with failed reperfusion following fibrinolytic therapy in patients with STEMI: results of a retrospective study.The effect of statins on the no-reflow phenomenon: an observational study in patients with hyperglycemia before primary angioplasty.Clinical significance of hyperglycaemia in acute coronary syndrome patients.Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction.One-Year Outcome of Intensive Insulin Therapy Combined to Glucose-Insulin-Potassium in Acute Coronary Syndrome: A Randomized Controlled Study.
P2860
Q30425798-884FEB3A-C240-4530-8F27-77ECFB32055AQ33622028-4095011B-D4BD-4137-A25E-BDD8E869FCB1Q33749968-6CB16E68-7D96-483B-A5E3-C55B1318A544Q33776403-73370A80-AA8C-469D-8495-3762484E4D86Q34198009-ECDE2FBF-8767-46A9-B315-85493C049DA6Q34466743-704DFC02-CA1B-4416-BA69-F7395732C8D4Q34541855-74D13BB3-1B66-4413-81BC-3FA4672662C8Q35099613-AD0E6F40-DA8B-4BF0-92F0-2BF8C6303DD5Q35485016-EE266FFA-00F1-47E9-86CD-AD6608F19970Q35594787-81775776-9516-4AFC-8A6D-A3C37F577837Q35771073-DD833979-568D-44B6-BC89-7E222EE0504FQ35847886-FD75BA19-ADC6-4CB2-9D9C-F13B4C880C9BQ35993115-46A91BDE-F7ED-4635-8354-B5440EB5BC88Q36035243-A69A4064-DA29-416E-A81A-20D901412C8BQ36172918-91C84EB4-651C-46F9-A0FB-9082EEBB1A11Q36265720-3D0974D4-F4D6-4744-B9A9-D45207C027B2Q36333927-2FD3D40B-A307-4E02-977A-95E4A265A5D5Q36462622-7C4F0FE2-3510-4F7E-8D59-AB13AEA4A767Q36599646-4562EC5E-4D13-4816-B78B-3BB40BED6E95Q36608369-58D47FBF-CC20-4E00-9F16-0B5AA9DD0CC2Q37139613-B00741CF-9446-4D27-8FA7-5F9C4657FC32Q37311107-DA055150-D062-4362-AEFB-1E44C8673661Q37424485-77C97396-0CCB-4042-9C52-DEE6B889CD97Q37431525-4FF7AB9F-383C-4EAB-AC88-7F37462BE397Q37453099-01AB51E5-F504-49F4-8113-5D4BD292E00EQ37588828-EB796CB1-AA73-4C7D-9DD8-991A3CFFB141Q37765290-81FA7199-8BED-47A7-89AB-56686B67D428Q37779094-FB2CA787-B853-465A-AB6E-6A03C023174CQ37880139-175E21BE-CE8C-435F-AB72-764301391D89Q37917623-68113476-0359-4518-BD2F-EF9264D57DEFQ38895495-F47DACA8-668C-40B1-9F97-7ABC3340E6D2Q39301873-951BB185-CE5C-4EF1-8AD2-84ECEF8C5D53Q43013948-B2186A80-8719-4329-8494-6522EE26E91AQ44127712-F2031FFE-1AF7-413C-A040-59497BE3AE74Q44604672-C6B94929-74E0-46AB-99EB-499194B20FEEQ44649222-93163A38-9C03-4220-B2F9-948A0812EA95Q46069308-2F522453-E9A5-4516-8B30-4DF6082E550FQ46084864-1FCFBB7D-8236-4D71-8BE9-83AD9637BA1DQ46313291-472102F8-5FE4-4DA1-848E-9ADB0369C483Q46714574-588133C1-B5D5-4C00-9DBB-4AF280520D1C
P2860
Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Association between hyperglyce ...... h acute myocardial infarction.
@en
Association between hyperglyce ...... h acute myocardial infarction.
@nl
type
label
Association between hyperglyce ...... h acute myocardial infarction.
@en
Association between hyperglyce ...... h acute myocardial infarction.
@nl
prefLabel
Association between hyperglyce ...... h acute myocardial infarction.
@en
Association between hyperglyce ...... h acute myocardial infarction.
@nl
P2093
P921
P1476
Association between hyperglyce ...... h acute myocardial infarction.
@en
P2093
Atsushi Okamura
Hiroshi Ito
Katsuaki Asano
Katsuomi Iwakura
Kenshi Fujii
Koji Tanaka
Masashi Ikushima
Masatsugu Hori
Shigeo Kawano
Tadashi Kuroda
P356
10.1016/S0735-1097(02)02626-8
P407
P577
2003-01-01T00:00:00Z